Protagonist Therapeutics, Inc
PTGX
Revenue
8.78M
▲8.78M∞%
12 Months ChangeAssets
614.63M
▼-14.65M▼-2.33%
3 Months ChangeLiabilities
73.31M
▲4.47M▲6.50%
3 Months ChangeFree Cash Flow
-27.67M
▲6.69M▲19.46%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001104659-24-101688
2024-08-06
Form 10-Q
ID: 0001558370-24-011095
2024-08-06
Form 8-K
ID: 0001104659-24-086088
2024-06-26
Form 8-K
ID: 0001104659-24-075162
2024-05-07
Form 10-Q
ID: 0001558370-24-007081
2024-05-07
Form 8-K
ID: 0001104659-24-058036
2024-02-27
Form 8-K
ID: 0001104659-24-028208
2024-01-31
Form 8-K
ID: 0001104659-24-008787
2024-01-16
Form 8-K
ID: 0001104659-24-003903
2024-01-08
Form 8-K
ID: 0001104659-24-002073